Suppression of replicative senescence by rapamycin in rodent embryonic cells
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
The TOR (target of rapamycin) pathway is involved in aging in diverse organisms from yeast to mammals. We have previously demonstrated in human and rodent cells that mTOR converts stress-induced cell cycle arrest to irreversible senescence (geroconversion), whereas rapamycin decelerates or suppresses geroconversion during cell cycle arrest. Here, we investigated whether rapamycin can suppress replicative senescence of rodent cells. Mouse embryonic fibroblasts (MEFs) gradually acquired senescent morphology and ceased proliferation. Rapamycin decreased cellular hypertrophy, and SA-β-Gal staining otherwise developed by 4-6 passages, but it blocked cell proliferation, masking its effects on replicative lifespan. We determined that rapamycin inhibited pS6 at 100-300 pM and inhibited proliferation with IC(50) around 30 pM. At 30 pM, rapamycin partially suppressed senescence. However, the gerosuppressive effect was balanced by the cytostatic effect, making it difficult to suppress senescence without causing quiescence. We also investigated rat embryonic fibroblasts (REFs), which exhibited markers of senescence at passage 7, yet were able to slowly proliferate until 12-14 passages. REFs grew in size, acquired a large, flat cell morphology, SA-β-Gal staining and components of DNA damage response (DDR), in particular, γH2AX/53BP1 foci. Incubation of REFs with rapamycin (from passage 7 to passage 10) allowed REFs to overcome the replicative senescence crisis. Following rapamycin treatment and removal, a fraction of proliferating REFs gradually increased and senescent phenotype disappeared completely by passage 24.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 1×
“The onset of cellular senescence does not simply reflect the accumulation of cell divisions, but can be prematurely activated in response to oncogenic stimuli.(7,8) Senescence can be accelerated by expression of Ras, MEK, Akt(7-14) as well as depletion of TSC2,(15,16) all manipulations that activate mTOR (target of ra…”
BackgroundRapamycin fed late in life extends lifespan in genetically heterogeneous mice
Harrison, D. E., Strong, R., Sharp, Z. D., Nelson, J. F., Astle, C. M., Flurkey, K., Nadon, N. L., Wilkinson, J. E., Frenkel, K., Carter, C. S., et al. (2009) · Nature · doi:10.1038/nature08221 · Cited by 3,766
Brugarolas, J., Lei, K., Hurley, R. L., Manning, B. D., Reiling, J. H., Hafen, E., Witters, L. A., Ellisen, L. W., & Kaelin, W. G. (2004) · Genes & Development · doi:10.1101/gad.1256804 · Cited by 1,384
Ribosomal Protein S6 Kinase 1 Signaling Regulates Mammalian Life Span
Selman, C., Tullet, J. M. A., Wieser, D., Irvine, E., Lingard, S. J., Choudhury, A. I., Claret, M., Al-Qassab, H., Carmignac, D., Ramadani, F., et al. (2009) · Science · doi:10.1126/science.1177221 · Cited by 1,120
Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts
Parrinello, S., Samper, E., Krtolica, A., Goldstein, J., Melov, S., & Campisi, J. (2003) · Nature Cell Biology · doi:10.1038/ncb1024 · Cited by 1,116
Influence of TOR kinase on lifespan in C. elegans
Vellai, T., Takacs-Vellai, K., Zhang, Y., Kovacs, A. L., Orosz, L., & Müller, F. (2003) · Nature · doi:10.1038/426620a · Cited by 1,057
Lin, A. W., Barradas, M., Stone, J. C., van Aelst, L., Serrano, M., & Lowe, S. W. (1998) · Genes & Development · doi:10.1101/gad.12.19.3008 · Cited by 945
Senescence of human fibroblasts induced by oncogenic Raf
Zhu, J., Woods, D., McMahon, M., & Bishop, J. M. (1998) · Genes & Development · doi:10.1101/gad.12.19.2997 · Cited by 826
Sch9 Is a Major Target of TORC1 in Saccharomyces cerevisiae
Urban, J., Soulard, A., Huber, A., Lippman, S., Mukhopadhyay, D., Deloche, O., Wanke, V., Anrather, D., Ammerer, G., Riezman, H., et al. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.04.020 · Cited by 798
Hayflick, his limit, and cellular ageing
Shay, J. W., & Wright, W. E. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35036093 · Cited by 764
Research works printed but not linked: 53
- 10.1126/science.279.5349.349 · DOI · Paper page
- 10.1038/sj.onc.1202261 · DOI
- 10.1016/S0955-0674(00)00278-7 · DOI · Paper page
- 10.1101/gad.11.5.663 · DOI · Paper page
- Sewing A, 1997, Mol Cell Biol, 17, 5588, 10.1128/MCB.17.9.5588 · DOI · Paper page
- Woods D, 1997, Mol Cell Biol, 17, 5598, 10.1128/MCB.17.9.5598 · DOI · Paper page
- Kerkhoff E, 1998, Cancer Res, 58, 1636
- 10.1128/MCB.26.6.2202-2214.2006 · DOI
- 10.1172/JCI200317222 · DOI
- 10.1172/JCI28984 · DOI · Paper page
- 10.1101/gad.1212704 · DOI · Paper page
- 10.1038/ng1494 · DOI · Paper page
- 10.1016/j.cell.2006.01.016 · DOI · Paper page
- 10.1016/j.molmed.2007.04.002 · DOI · Paper page
- 10.4161/cc.10.12.15858 · DOI · Paper page
- 10.1038/nrm2672 · DOI · Paper page
- 10.4161/cc.7.21.6919 · DOI · Paper page
- 10.4161/cc.8.12.8809 · DOI · Paper page
- 10.4161/cc.8.12.8810 · DOI · Paper page
- Demidenko ZN, 2009, Aging, 1, 1008, 10.18632/aging.100115 · DOI · Paper page
- 10.4161/cc.8.24.10215 · DOI · Paper page
- 10.4161/cc.9.19.13160 · DOI · Paper page
- Leontieva OV, 2010, Aging, 2, 924, 10.18632/aging.100265 · DOI · Paper page
- 10.4161/cc.9.21.13584 · DOI · Paper page
- 10.1371/journal.pone.0026126 · DOI · Paper page
- 10.1089/rej.2008.0722 · DOI · Paper page
- 10.4161/cc.8.7.8045 · DOI · Paper page
- 10.1038/scientificamerican0112-32 · DOI
- 10.1101/gad.1381406 · DOI · Paper page
- 10.1126/science.1115535 · DOI · Paper page
- 10.1242/dev.01255 · DOI · Paper page
- 10.1016/j.cub.2004.03.059 · DOI · Paper page
- 10.1089/rej.2009.0903 · DOI · Paper page
- 10.1016/j.cmet.2009.11.010 · DOI · Paper page
- 10.1093/gerona/glq178 · DOI · Paper page
- 10.4161/cc.10.24.18486 · DOI · Paper page
- 10.1016/j.cmet.2007.02.009 · DOI · Paper page
- 10.4161/auto.8824 · DOI · Paper page
- Pan Y, 2009, Aging, 1, 131, 10.18632/aging.100016 · DOI · Paper page
- 10.1016/j.cmet.2011.03.018 · DOI · Paper page
- Leontieva OV, 2011, Aging, 3, 1078, 10.18632/aging.100402 · DOI · Paper page
- Fabrizio P, 2011, Aging, 3, 1127, 10.18632/aging.100412 · DOI
- 10.4161/cc.11.2.18959 · DOI
- 10.1371/journal.pgen.0010069 · DOI · Paper page
- 10.1016/j.cell.2008.02.037 · DOI · Paper page
- 10.1146/annurev.cellbio.23.090506.123509 · DOI · Paper page
- Ha CW, 2011, Aging, 3, 319, 10.18632/aging.100299 · DOI
- 10.1128/MCB.24.12.5459-5474.2004 · DOI · Paper page
- 10.1128/MCB.25.14.5834-5845.2005 · DOI · Paper page
- 10.1128/MCB.26.10.3955-3965.2006 · DOI · Paper page
- 10.1016/j.molcel.2006.01.010 · DOI · Paper page
- 10.1128/MCB.01393-10 · DOI · Paper page
- 10.4161/cc.20683 · DOI · Paper page
Cited by
Cellular senescence drives age-dependent hepatic steatosis
Ogrodnik, M., Miwa, S., Tchkonia, T., Tiniakos, D., Wilson, C. L., Lahat, A., Day, C. P., Burt, A., Palmer, A., Anstee, Q. M., et al. (2017) · Nature Communications · doi:10.1038/ncomms15691 · Cited by 1,044
Cellular senescence and its effector programs
Salama, R., Sadaie, M., Hoare, M., & Narita, M. (2014) · Genes & Development · doi:10.1101/gad.235184.113 · Cited by 855
Mitochondria are required for pro-ageing features of the senescent phenotype
Correia‐Melo, C., Marques, F. D., Anderson, R., Hewitt, G., Hewitt, R., Cole, J., Carroll, B. M., Miwa, S., Birch, J., Merz, A., et al. (2016) · The EMBO Journal · doi:10.15252/embj.201592862 · Cited by 796
mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype
Herranz, N., Gallage, S., Mellone, M., Wuestefeld, T., Klotz, S., Hanley, C. J., Raguz, S., Acosta, J. C., Innes, A. J., Banito, A., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3225 · Cited by 788
Ageing, Cellular Senescence and Neurodegenerative Disease
Kritsilis, M., V. Rizou, S., Koutsoudaki, P. N., Evangelou, K., Gorgoulis, V. G., & Papadopoulos, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102937 · Cited by 448
Effect of rapamycin on aging and age-related diseases—past and future
Selvarani, R., Mohammed, S., & Richardson, A. (2021) · GeroScience · doi:10.1007/s11357-020-00274-1 · Cited by 290
Senescence as a therapeutic target in cancer and age-related diseases
McHugh, D., Durán, I., & Gil, J. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01074-4 · Cited by 197
Senescence and senotherapeutics: a new field in cancer therapy
Myrianthopoulos, V., Evangelou, K., Vasileiou, P. V. S., Cooks, T., Vassilakopoulos, T. P., Pangalis, G. A., Kouloukoussa, M., Kittas, C., Georgakilas, A. G., & Gorgoulis, V. G. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.08.006 · Cited by 160
Replicatively senescent cells are arrested in G1 and G2 phases
Mao, Z., Ke, Z., Gorbunova, V., & Seluanov, A. (2012) · Aging · doi:10.18632/aging.100467 · Cited by 128
Thapa, R. K., Nguyen, H. T., Jeong, J.-H., Kim, J. R., Choi, H.-G., Yong, C. S., & Kim, J. O. (2017) · Scientific Reports · doi:10.1038/srep43299 · Cited by 115
Reversal of phenotypes of cellular senescence by pan-mTOR inhibition
Walters, H. E., Deneka-Hannemann, S., & Cox, L. S. (2016) · Aging · doi:10.18632/aging.100872 · Cited by 113
Cellular senescence in the aging brain: A promising target for neurodegenerative diseases
Sahu, M. R., Rani, L., Subba, R., & Mondal, A. C. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2022.111675 · Cited by 75
Metadata
- Authors
- Pospelova, T. V., Leontieva, O. V., Bykova, T. V., Zubova, S. G., Pospelov, V. A., & Blagosklonny, M. V.
- Venue
- Cell Cycle
- Publisher
- Informa UK Limited
- Published
- 2012-06-15
- Volume
- 11
- Issue
- 12
- Pages
- 2402-2407
- ISSN
- 1538-4101 (ISSN-L)
- 1551-4005
- OpenAlex
- W2022738422
- Cited by
- 83
- References
- 21
- FWCI
- 6.79
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.